Cargando…

Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver Transplantation

OBJECTIVE: Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver transplantation (LDLT). Several biomarkers have been used to investigate this event. We conducted a prospective controlled study to determine the activities of the basic fibroblast growth factor (FG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, King-Wah, Nakano, Toshiaki, Chen, Kuang-Den, Hsu, Li-Wen, Lai, Chia-Yun, Huang, Ching-Yin, Cheng, Yu-Fan, Goto, Shigeru, Chen, Chao-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433208/ https://www.ncbi.nlm.nih.gov/pubmed/25978323 http://dx.doi.org/10.1371/journal.pone.0124943

Ejemplares similares

Cytochrome P450 in living donor liver transplantation
por: Chiu, King-Wah, et al.
Publicado: (2015)

Pyrosequencing to Identify Homogeneous Phenomenon When Using Recipients/Donors with Different CYP3A5*3 Genotypes in Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2013)

Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2016)

Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2018)

Identification of IL-28B Genotype Modification in Hepatocytes after Living Donor Liver Transplantation by Laser Capture Microdissection and Pyrosequencing Analysis
por: Chiu, King-Wah, et al.
Publicado: (2018)

Biological interactions of CYP2C19 genotypes with CYP3A4*18, CYP3A5*3, and MDR1-3435 in living donor liver transplantation recipients
por: Chiu, King-Wah, et al.
Publicado: (2013)

Induction of Antinuclear Antibodies by De Novo Autoimmune Hepatitis Regulates Alloimmune Responses in Rat Liver Transplantation
por: Nakano, Toshiaki, et al.
Publicado: (2013)

HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation
por: Lin, Shu-Hsien, et al.
Publicado: (2021)

Liver Graft Pathology and Low Serum 25-Hydroxyvitamin D after Living Donor Liver Transplantation
por: Lin, Shu-Hsien, et al.
Publicado: (2022)

MicroRNA-301a inhibition enhances the immunomodulatory functions of adipose-derived mesenchymal stem cells by induction of macrophage M2 polarization
por: Hsu, Li-Wen, et al.
Publicado: (2020)

Liver Graft MicroRNAs Expression in Different Etiology of Acute Jaundice after Living Donor Liver Transplantation
por: Lin, Shu-Hsien, et al.
Publicado: (2022)

Immunological and Regenerative Aspects of Hepatic Mast Cells in Liver Allograft Rejection and Tolerance
por: Nakano, Toshiaki, et al.
Publicado: (2012)

Complications of percutaneous liver biopsy in living donor liver transplantation: Two case reports
por: Chiu, King-Wah, et al.
Publicado: (2018)

Immunohistochemistry Staining-Proven Cytomegalovirus Colitis in Living Donor Liver Transplantation
por: Lin, Shu-Hsien, et al.
Publicado: (2022)

Assessment of relevant factors with respect to psychosocial properties in potential living donor candidates before liver transplantation
por: Wu, Ming-Kung, et al.
Publicado: (2018)

Adaptor protein Shc acts as an immune-regulator for the LPS-stimulated maturation of bone marrow-derived dendritic cells
por: Chen, Kuang-Den, et al.
Publicado: (2011)

MicroRNA-27b Enhances the Hepatic Regenerative Properties of Adipose-Derived Mesenchymal Stem Cells
por: Chen, Kuang-Den, et al.
Publicado: (2016)

Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?
por: Saidi, R. F., et al.
Publicado: (2013)

Living Donor Re-transplantation for Repeated Acute Liver Failure
por: Ince, V., et al.
Publicado: (2018)

Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma
por: Akamatsu, Nobuhisa, et al.
Publicado: (2014)

Nuclear Antigens and Auto/Alloantibody Responses: Friend or Foe in Transplant Immunology
por: Nakano, Toshiaki, et al.
Publicado: (2013)

The Perioperatively Altered Neutrophil-to-Lymphocyte Ratio Associates with Impaired DNA Damage Response in Liver Transplantation Recipients with Hepatocellular Carcinoma
por: Chen, Kuang-Den, et al.
Publicado: (2021)

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
por: Liang, Hsin-Rou, et al.
Publicado: (2021)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD
por: Huang, Kuang-Tzu, et al.
Publicado: (2020)

Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
por: Chen, Li-Ping, et al.
Publicado: (2015)

Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive Biomarker
por: Nakano, Toshiaki, et al.
Publicado: (2023)

De-novo hepatocellular carcinoma after pediatric living donor liver transplantation
por: Torres-Landa, Samuel, et al.
Publicado: (2017)

Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021)

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Infection in Living Donor Liver Transplantation Leads to Increased Risk of Adverse Renal Outcomes
por: Hsu, Kao-Ming, et al.
Publicado: (2022)

Donor sex and donor-recipient sex disparity do not affect hepatocellular carcinoma recurrence after living donor liver transplantation
por: Oh, Rak Kyun, et al.
Publicado: (2023)

Petersen’s hernia after living donor liver transplantation
por: Sakamoto, Sodai, et al.
Publicado: (2017)

Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells
por: Chen, Chien-Chih, et al.
Publicado: (2017)

Using 3D Microscope for Hepatic Artery Reconstruction in Living Donor Liver Transplant
por: Lin, Ching-Min, et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
por: Sotiropoulos, Georgios C., et al.
Publicado: (2018)

Sarcopenia adversely impacts postoperative complications in living-donor liver transplantation recipients
por: Wu, Mei-Yun, et al.
Publicado: (2021)

Comparing Emotional Adjustment of Living-donor and Deceased-donor Kidney Transplant Patients
por: Lai, Yousheng Lester, et al.
Publicado: (2020)

Living donor liver transplantation /
Publicado: (2007)

Outcome of Living-Donor Liver Transplantation Using Grafts from Donors Treated for Fatty Liver
por: Fujii, Yuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_78tlmkqqrod81817nmjdvti0rf